Literature DB >> 2900639

Acromegalic arthropathy. Characteristics and response to therapy.

M W Layton1, E J Fudman, A Barkan, E M Braunstein, I H Fox.   

Abstract

Arthropathy was assessed in 19 patients with active acromegaly. Axial or peripheral arthropathy was present in 10 patients, was located most often in large joints or the lumbosacral spine, and was osteoarthritic in nature. The mean duration of acromegaly in patients with arthropathy was 21.6 years, while the mean duration in patients without arthropathy was 7.9 years. A mild-to-moderate improvement in symptoms, estimated functional ability, and crepitus occurred in 8 of 9 patients who were prospectively examined during therapy to lower production of growth hormone. We conclude that this therapy did improve the symptoms of acromegalic arthropathy. Whether objective structural improvements occur remains unclear.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2900639     DOI: 10.1002/art.1780310813

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  15 in total

Review 1.  A history of acromegaly.

Authors:  R Sheaves
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

2.  Acromegalic arthropathy.

Authors:  A L Barkan
Journal:  Pituitary       Date:  2001-09       Impact factor: 4.107

Review 3.  Osteoarthritis: the cause not result of joint failure?

Authors:  C W Hutton
Journal:  Ann Rheum Dis       Date:  1989-11       Impact factor: 19.103

4.  Bilateral slipped capital femoral epiphysis occuring in an adult with acromegalic gigantism.

Authors:  A Feydy; R Y Carlier; D Mompoint; G Rougereau; A Patel; C Vallée
Journal:  Skeletal Radiol       Date:  1997-03       Impact factor: 2.199

5.  Arthropathy in acromegaly: a questionnaire-based estimation of motor disability and its relation with quality of life and work productivity.

Authors:  L M Fatti; B Cangiano; G Vitale; L Persani; G Mantovani; E Sala; M Arosio; P Maffei; F Dassie; M Mormando; A Giampietro; L Tanda; E R Masiello; E Nazzari; D Ferone; S Corbetta; E Passeri; F Guaraldi; S Grottoli; S Cannavò; M L T Torre; D Soranna; A Zambon; F Cavagnini; M Scacchi
Journal:  Pituitary       Date:  2019-10       Impact factor: 4.107

Review 6.  Rheumatic manifestations of pituitary tumors.

Authors:  S Stavrou; D L Kleinberg
Journal:  Curr Rheumatol Rep       Date:  2001-10       Impact factor: 4.592

Review 7.  Epidemiology of acromegaly.

Authors:  I M Holdaway; C Rajasoorya
Journal:  Pituitary       Date:  1999-06       Impact factor: 4.107

8.  Ultrasonographic measurement of femoral cartilage thickness in acromegalic patients.

Authors:  Murat Karkucak; İbrahim Batmaz; Nadim Civan; Fatih Kilinc; Erhan Capkin; Mustafa Akif Sariyildiz; Melek Aslan Garipoğlu; Mustafa Avni Onder; Levent Ozcakar
Journal:  Clin Rheumatol       Date:  2014-02-27       Impact factor: 2.980

Review 9.  Current diagnosis of acromegaly.

Authors:  Rocio A Cordero; Ariel L Barkan
Journal:  Rev Endocr Metab Disord       Date:  2008-03       Impact factor: 6.514

Review 10.  Acromegaly. Recognition and treatment.

Authors:  C A Jaffe; A L Barkan
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.